Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-018545
Filing Date
2016-08-05
Accepted
2016-08-04 18:54:27
Documents
80
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20160630x10q.htm 10-Q 1162131
2 EXHIBIT 10.1 ex06302016r1101.htm EX-10.1 202085
3 EXHIBIT 31.1 ex06302016311.htm EX-31.1 17369
4 EXHIBIT 31.2 ex06302016312.htm EX-31.2 17422
5 EXHIBIT 32.1 ex06302016321.htm EX-32.1 10363
6 EXHIBIT 32.2 ex06302016322.htm EX-32.2 10470
13 pipelinechartq2.jpg GRAPHIC 64587
  Complete submission text file 0001628280-16-018545.txt   6621428

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rtrx-20160630.xml EX-101.INS 1261823
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20160630.xsd EX-101.SCH 52826
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20160630_cal.xml EX-101.CAL 87801
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20160630_def.xml EX-101.DEF 262086
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20160630_lab.xml EX-101.LAB 673533
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20160630_pre.xml EX-101.PRE 380902
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 161808763
SIC: 2834 Pharmaceutical Preparations